4-butyrolactone has been researched along with protocatechuic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawabata, K; Matsunaga, K; Mori, H; Nishikawa, A; Sugie, S; Tanakamaru, Y; Yamada, Y | 1 |
| Andersson, DR; Nissbrandt, H; Shahabi, HN | 1 |
2 other study(ies) available for 4-butyrolactone and protocatechuic acid
| Article | Year |
|---|---|
Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone(KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice.
Topics: 4-Butyrolactone; Adenoma; Animals; Anticarcinogenic Agents; Carcinogens; Drug Screening Assays, Antitumor; Female; Hydroxybenzoates; Lung Neoplasms; Methyl Methanesulfonate; Mice; Mice, Inbred A; Nitrosamines; Retinoids | 1999 |
Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Extracellular Space; Free Radicals; GABA Modulators; Hydroxybenzoates; In Vitro Techniques; Isoflurane; Ketamine; Male; Microdialysis; Parabens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Substantia Nigra; Synaptic Transmission; Tetrodotoxin; Xylazine | 2008 |